NCT03297489View on ClinicalTrials.gov

Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 6, 2017

Primary Completion Date

February 15, 2021

Study Completion Date

February 15, 2021

Conditions
Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaStage I Ovarian CancerStage IA Ovarian CancerStage IB Ovarian CancerStage IC Ovarian CancerStage II Ovarian CancerStage IIA Ovarian CancerStage IIB Ovarian CancerStage IIC Ovarian CancerStage III Ovarian CancerStage IIIA Ovarian CancerStage IIIB Ovarian CancerStage IIIC Ovarian CancerStage IV Ovarian Cancer
Interventions
PROCEDURE

Diagnostic Microscopy

Undergo observation via intravital microscopy

DRUG

Fluorescein Sodium Injection

Given IV

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT03297489 - Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer | Biotech Hunter | Biotech Hunter